Treeway

In their quest for answers they have decided to look for it themselves. Supported by people from the industry and research world they aim to develop an adequate therapy for Amyotrophic Lateral Sclerosis and move into clinical phase within 18 months. Both founders are also the initiators behind Project MinE, the largest genomic research project to date for their disease.